William Stevenson, MD
Surgery · Washington Court House, OHNPI 1922181528
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,000 of the $5,449 with a category attached, or 91.8%. Biotronik Inc. accounts for 91.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $5,053 and has fallen 99.6% since, to $19 in 2025.
Across 17 payments — averaging $320.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$5K
- AbbVie$125
- Smith+Nephew$120
- Medtronic$68
- Nevro Corp.$55
- Phathom Pharmaceuticals, Inc.$53
- plus $28 from 1 others
What the payments were for
- Speaking & faculty fees$5,00092%
- Travel & lodging$250%
- Food & beverage$4248%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 1 | $5,000 |
| AbbVie | 1 | $125 |
| Smith+Nephew | 8 | $120 |
| Medtronic(2 entities) | 3 | $68 |
| Nevro Corp. | 1 | $55 |
| Phathom Pharmaceuticals, Inc. | 1 | $53 |
| Intuitive Surgical | 2 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$125
How this compares
$5,449 in reported general payments places this provider in the 70th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $136 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $49 |
Paid to pharmacies, not to this prescriber.
Other surgery in Washington Court House
- Jonathan ThompsonWest Chester$2.1M
- Raymond OndersCleveland$1.2M
- Neilendu KunduCleveland$808K
- Michael MearaColumbus$808K
- Chase WehrleCleveland$741K
- Craig JarrettCleveland$622K
- Greg StarleyCuyahoga Falls$594K
- Ihya GorgunCleveland$527K
- Marshall SpaldingColumbus$450K
- Jason ShoemakerDublin$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.